Transplantation: Personalizing induction therapy in kidney transplantation.

Nature reviews. Nephrology

PubMedID: 19855425

Aull MJ, Suthanthiran M. Transplantation: Personalizing induction therapy in kidney transplantation. Nat Rev Nephrol. 2009;5(11):619-20.
Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.